Cargando…

Central and cerebrovascular effects of leg crossing in humans with sympathetic failure

Leg crossing increases arterial pressure and combats symptomatic orthostatic hypotension in patients with sympathetic failure. This study compared the central and cerebrovascular effects of leg crossing in patients with sympathetic failure and healthy controls. We addressed the relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales: Harms, Mark P.M., Wieling, Wouter, Colier, Willy N.J.M., Lenders, Jacques W.M., Secher, Niels H., van Lieshout, Johannes J.
Formato: Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825733/
https://www.ncbi.nlm.nih.gov/pubmed/19832700
http://dx.doi.org/10.1042/CS20090038
_version_ 1782177833399877632
author Harms, Mark P.M.
Wieling, Wouter
Colier, Willy N.J.M.
Lenders, Jacques W.M.
Secher, Niels H.
van Lieshout, Johannes J.
author_facet Harms, Mark P.M.
Wieling, Wouter
Colier, Willy N.J.M.
Lenders, Jacques W.M.
Secher, Niels H.
van Lieshout, Johannes J.
author_sort Harms, Mark P.M.
collection PubMed
description Leg crossing increases arterial pressure and combats symptomatic orthostatic hypotension in patients with sympathetic failure. This study compared the central and cerebrovascular effects of leg crossing in patients with sympathetic failure and healthy controls. We addressed the relationship between MCA V(mean) (middle cerebral artery blood velocity; using transcranial Doppler ultrasound), frontal lobe oxygenation [O(2)Hb (oxyhaemoglobin)] and MAP (mean arterial pressure), CO (cardiac output) and TPR (total peripheral resistance) in six patients (aged 37–67 years; three women) and age- and gender-matched controls during leg crossing. In the patients, leg crossing increased MAP from 58 (42–79) to 72 (52–89) compared with 84 (70–95) to 90 (74–94) mmHg in the controls. MCA V(mean) increased from 55 (38–77) to 63 (45–80) and from 56 (46–77) to 64 (46–80) cm/s respectively (P<0.05), with a larger rise in O(2)Hb [1.12 (0.52–3.27)] in the patients compared with the controls [0.83 (−0.11 to 2.04) μmol/l]. In the control subjects, CO increased 11% (P<0.05) with no change in TPR. By contrast, in the patients, CO increased 9% (P<0.05), but also TPR increased by 13% (P<0.05). In conclusion, leg crossing improves cerebral perfusion and oxygenation both in patients with sympathetic failure and in healthy subjects. However, in healthy subjects, cerebral perfusion and oxygenation were improved by a rise in CO without significant changes in TPR or MAP, whereas in patients with sympathetic failure, cerebral perfusion and oxygenation were improved through a rise in MAP due to increments in both CO and TPR.
format Text
id pubmed-2825733
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-28257332010-02-23 Central and cerebrovascular effects of leg crossing in humans with sympathetic failure Harms, Mark P.M. Wieling, Wouter Colier, Willy N.J.M. Lenders, Jacques W.M. Secher, Niels H. van Lieshout, Johannes J. Clin Sci (Lond) Research Article Leg crossing increases arterial pressure and combats symptomatic orthostatic hypotension in patients with sympathetic failure. This study compared the central and cerebrovascular effects of leg crossing in patients with sympathetic failure and healthy controls. We addressed the relationship between MCA V(mean) (middle cerebral artery blood velocity; using transcranial Doppler ultrasound), frontal lobe oxygenation [O(2)Hb (oxyhaemoglobin)] and MAP (mean arterial pressure), CO (cardiac output) and TPR (total peripheral resistance) in six patients (aged 37–67 years; three women) and age- and gender-matched controls during leg crossing. In the patients, leg crossing increased MAP from 58 (42–79) to 72 (52–89) compared with 84 (70–95) to 90 (74–94) mmHg in the controls. MCA V(mean) increased from 55 (38–77) to 63 (45–80) and from 56 (46–77) to 64 (46–80) cm/s respectively (P<0.05), with a larger rise in O(2)Hb [1.12 (0.52–3.27)] in the patients compared with the controls [0.83 (−0.11 to 2.04) μmol/l]. In the control subjects, CO increased 11% (P<0.05) with no change in TPR. By contrast, in the patients, CO increased 9% (P<0.05), but also TPR increased by 13% (P<0.05). In conclusion, leg crossing improves cerebral perfusion and oxygenation both in patients with sympathetic failure and in healthy subjects. However, in healthy subjects, cerebral perfusion and oxygenation were improved by a rise in CO without significant changes in TPR or MAP, whereas in patients with sympathetic failure, cerebral perfusion and oxygenation were improved through a rise in MAP due to increments in both CO and TPR. Portland Press Ltd. 2010-02-09 /pmc/articles/PMC2825733/ /pubmed/19832700 http://dx.doi.org/10.1042/CS20090038 Text en © 2010 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by-nc/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Harms, Mark P.M.
Wieling, Wouter
Colier, Willy N.J.M.
Lenders, Jacques W.M.
Secher, Niels H.
van Lieshout, Johannes J.
Central and cerebrovascular effects of leg crossing in humans with sympathetic failure
title Central and cerebrovascular effects of leg crossing in humans with sympathetic failure
title_full Central and cerebrovascular effects of leg crossing in humans with sympathetic failure
title_fullStr Central and cerebrovascular effects of leg crossing in humans with sympathetic failure
title_full_unstemmed Central and cerebrovascular effects of leg crossing in humans with sympathetic failure
title_short Central and cerebrovascular effects of leg crossing in humans with sympathetic failure
title_sort central and cerebrovascular effects of leg crossing in humans with sympathetic failure
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825733/
https://www.ncbi.nlm.nih.gov/pubmed/19832700
http://dx.doi.org/10.1042/CS20090038
work_keys_str_mv AT harmsmarkpm centralandcerebrovasculareffectsoflegcrossinginhumanswithsympatheticfailure
AT wielingwouter centralandcerebrovasculareffectsoflegcrossinginhumanswithsympatheticfailure
AT colierwillynjm centralandcerebrovasculareffectsoflegcrossinginhumanswithsympatheticfailure
AT lendersjacqueswm centralandcerebrovasculareffectsoflegcrossinginhumanswithsympatheticfailure
AT sechernielsh centralandcerebrovasculareffectsoflegcrossinginhumanswithsympatheticfailure
AT vanlieshoutjohannesj centralandcerebrovasculareffectsoflegcrossinginhumanswithsympatheticfailure